Nektar Therapeutics (NKTR)
77.02
+1.31
(+1.73%)
USD |
NASDAQ |
Apr 02, 16:00
77.30
+0.28
(+0.36%)
After-Hours: 19:32
Nektar Therapeutics Research and Development Expense (TTM) : 117.30M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 2.052B |
| Eli Lilly & Co. | 13.34B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Rigel Pharmaceuticals, Inc. | 33.30M |
| Esperion Therapeutics, Inc. | 47.85M |